Pericarditis Clinical Trial
Official title:
Noise of Airplanes a Factor of Risk for the Health of the Heart in Pilots and Crew in Operations of the F16 Airplane
Study of noise generated by military-type aircraft and equipment maintenance in relation to
non-auditory effects that impact with the body of the crew and ground staff can cause
cardiac pathologies
Hypothesis of work: The pilots and the technical personnel of maintenance that work before
the exhibition of noise generated by planes hunt F-16, or equipments of maintenance of the
same ones, present major risk of a cardiac affectation, which demonstrates in changes in the
normal pace of the heart, in his function of bomb or in hemodynamic conditions.
The work area military airport is characterized by low frequency noise in sound pressure
levels exceeding 100 dB, smashing into the body of pilots and ground staff.
It found variations in the thickness of the pericardium and deviation measures ejection
fraction
;
Observational Model: Cohort, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03253315 -
Management of Pericarditis in Children.
|
N/A | |
Recruiting |
NCT02754713 -
Prognostic Biomarkers in Patients With Acute Pericarditis
|
N/A | |
Completed |
NCT00235079 -
Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.
|
Phase 4 | |
Completed |
NCT04906720 -
Post-Ablation Pericarditis Reduction Study
|
Phase 2 | |
Not yet recruiting |
NCT05805930 -
Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children
|
Phase 3 | |
Not yet recruiting |
NCT06411340 -
Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR)
|
||
Terminated |
NCT00946907 -
Benign Acute Pericarditis: Brief Versus Longer Treatment Using Aspirin
|
Phase 4 | |
Not yet recruiting |
NCT05925790 -
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels
|
||
Recruiting |
NCT04294771 -
JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
|
||
Enrolling by invitation |
NCT04774549 -
Inflammatory Cardiomyopathy Bern Registry
|
||
Completed |
NCT02083510 -
Apolipoprotein CIII Reduction Via Colchicine
|
Phase 0 | |
Completed |
NCT04692766 -
Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03231449 -
A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
|
||
Completed |
NCT00128414 -
Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)
|
Phase 3 | |
Completed |
NCT00128453 -
Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences
|
Phase 3 | |
Recruiting |
NCT05046002 -
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
|
||
Recruiting |
NCT06103123 -
MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study
|
||
Completed |
NCT01395082 -
ACAM2000® Myopericarditis Registry
|